News

February 12, 2018February 12, 2018

Filament BioSolutions Partners with Canadian Academic Centers to Study Precision Nutritional Therapies

News

Filament BioSolutions announced a partnership with the University of Ottawa and the Children’s Hospital of Eastern Ontario (CHEO) to conduct a $7.4 million study of clinical applications of microbiome-based precision nutrition for ... Read more

February 9, 2018

Theravance and Janssen to Advance TD-1473 for Treatment of Inflammatory Bowel Diseases

News

Theravance Biopharma Ireland Limited, a Theravance Biopharma subsidiary, and Janssen Biotech have joined forces to develop and commercialize the investigational therapy TD-1473 as a treatment for inflammatory bowel diseases (IBDs) such ... Read more

February 6, 2018

New Apps Aid in IBD Monitoring and Patient Education

News

The American Gastroenterological Association (AGA) recently launched My IBD Manager, a new digital app for inflammatory bowel disease (IBD) patients. The app offers tools and features for patients, including a ... Read more

February 5, 2018February 5, 2018

Kenneth Rainin Foundation Gives $1.7M in ‘Synergy Awards’ for IBD Research

News

The Kenneth Rainin Foundation has given $1.7 million in prize money to support collaborative research into preventing and detecting inflammatory bowel disease (IBD). The Synergy Awards are aimed at getting experts ... Read more

February 2, 2018February 6, 2018

Natural Diet is Key to Preventing, Reversing Crohn’s in Children, Israeli Expert Says

News

HOLON, Israel — The children’s gastroenterologist Arie Levine isn’t shy about calling himself a pioneer, at least when it comes to the origins of Crohn’s disease and how to cure ... Read more

January 31, 2018January 31, 2018

More Severe IBD Boosts Risk for Non-alcoholic Fatty Liver Disease, Italian Study Suggests

News

The risk that inflammatory bowel disease (IBD) patients will develop non-alcoholic fatty liver disease (NAFLD) increases as IBD worsens, according to Italian researchers. Their study “Non-alcoholic fatty liver disease phenotypes ... Read more

January 29, 2018

Pandion Obtains $58 Million to Keep Developing Autoimmune and Bowel Disease Therapies

News

Pandion Therapeutics has obtained $58 million in financing to continue developing treatments for autoimmune and inflammatory diseases, including bowel disorders. Polaris Partners, Versant Ventures and Roche Venture Fund led the financing round. ... Read more

January 26, 2018January 26, 2018

Researchers Target Specific Gut Bacteria to Control Inflammation in Mice Study of Colitis

News

Researchers at UT Southwestern Medical Center have discovered a way to target a specific population of bacteria that promotes gut inflammation in mice. While more studies are needed, they believe ... Read more

January 24, 2018

U.S. Survey Sheds Light on How Ulcerative Colitis Affects Patients’ Lives

News

Two-thirds of ulcerative colitis patients believe the disease affects their personal relationships and half think it impacts their ability to obtain an education or their career, a U.S. survey shows. The UC ... Read more

January 22, 2018January 22, 2018

Lyfebulb, UnitedHealth Launch ‘Innovation Challenge’ Contest to Fight IBD

News

Lyfebulb and UnitedHealth Group will jointly launch an innovation challenge for new business and product ideas targeting inflammatory bowel disease (IBD). The challenge, to take place later this year, is ... Read more